Microbot Medical Inc Market Cap ($69.85 Million)
Market Cap & Net Worth: Microbot Medical Inc (MBOT)
Microbot Medical Inc market cap. Microbot Medical Inc (NASDAQ:MBOT) has a market capitalization of $69.85 Million ($69.85 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20437 globally and #4654 in its home market, demonstrating a 6.79% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Microbot Medical Inc's stock price $1.04 by its total outstanding shares 67164801 (67.16 Million). Also see MBOT operating cash flow for how efficiently the company converts equity into cash flow.
Microbot Medical Inc Market Cap History (2015–2026)
Microbot Medical Inc market cap history from 2015 to 2026. Data shows change from $45.32 Billion to $69.85 Million (-44.15% CAGR). Check current stock price of Microbot Medical Inc for real-time trading data and today's change.
Index Memberships
Microbot Medical Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.00% | #571 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #1953 of 3165 |
Weight: Microbot Medical Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Microbot Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Microbot Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Microbot Medical Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MBOT by Market Capitalization
Companies near Microbot Medical Inc in the global market cap rankings as of November 4, 2026. Also see MBOT total assets for a full breakdown of the balance sheet.
Key companies related to Microbot Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Microbot Medical Inc (2015–2026)
Market capitalization of Microbot Medical Inc from 2015 to today. Between 2015 and today, Microbot Medical Inc's market cap moved from $45.32 Billion to $ 69.85 Million, with a yearly change of -44.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $69.85 Million | -48.00% |
| 2025 | $134.33 Million | +78.57% |
| 2024 | $75.22 Million | -31.71% |
| 2023 | $110.15 Million | -45.51% |
| 2022 | $202.17 Million | -59.87% |
| 2021 | $503.74 Million | +8.85% |
| 2020 | $462.77 Million | -32.25% |
| 2019 | $683.07 Million | +491.28% |
| 2018 | $115.52 Million | -88.76% |
| 2017 | $1.03 Billion | -83.28% |
| 2016 | $6.15 Billion | -86.44% |
| 2015 | $45.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Microbot Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $69.85 Million USD |
| MoneyControl | $69.85 Million USD |
| MarketWatch | $69.85 Million USD |
| marketcap.company | $69.85 Million USD |
| Reuters | $69.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Microbot Medical Inc
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, periph… Read more